[Syphilis: serologic survey in different socioeconomic groups in the city of Niteroi].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to R D Azulay.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Inhibitory serum factors in certain infectious diseases (leprosy, tuberculosis, histoplasmosis) and malignant conditions (Hodgkin's disease, primary intracranial neoplasms) are said to be partially responsible for decreased cell-mediated immunity (CMI) and consequent anergy. The immunologic derangement in leprosy is not yet completely understood. In order to determine the effect of sera from patients with leprosy upon the rosetting capacity of normal T. lymphocytes, sera from untreated lepromatous (L) and tuberculoid (T) patients were studied. Control sera were obtained from normal volunteers and from patients with other dermatologic conditions (contact dermatitis and leg ulcer). The data indicated that test sera did not inhibit either spontaneous E rosette formation or active rosetting of normal lymphocytes.
Explore the source record for details and available documents.
The delayed hypersensitivity to antibiotics existing in Brazil, including the systemically administered, is analyzed. The sulphanilamide, penicillin, neomycin, oxacillin, oxitetraciclyne, chloramphenicol and kanamycin were the more positive to the contact test. We do not find any difference in the test between sex and race. The positivity was 7,5 times higher in adults than in children. In spite the high positivity in atopic patients we could not demonstrate the same in patients with other allergic procesus history.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.